| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.6 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |